(Q53164841)
Statements
The Dana Farber consortium protocol (DFCP) vs. classic Hyper-CVAD for treatment of acute lymphoblastic leukemia in patients <50 Y. Single institution experience (English)
Amal S Alabdulwahab
Hussein G Elsayed
Mohamed A Sherisher
Khalofa Alghamdi
Wafaa M Elbjeirami